Literature DB >> 26456544

Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study.

Nicolas D Verheyen1, Katharina Kienreich2, Martin Gaksch2, Adriana J van Ballegooijen3, Martin R Grübler2, Briain Ó Hartaigh4,5, Johannes Schmid1, Astrid Fahrleitner-Pammer2, Elisabeth Kraigher-Krainer6, Caterina Colantonio1, Evgeny Belyavskiy6, Gerlies Treiber2, Cristiana Catena7, Helmut Brussee1, Burkert Pieske1,6, Winfried März8,9,10, Andreas Tomaschitz1,6,11, Stefan Pilz2,12.   

Abstract

High parathyroid hormone (PTH) has been linked with high blood pressure (BP), but the relationship with 24-hour ambulatory blood pressure monitoring is largely unknown. The authors therefore analyzed cross-sectional data of 292 hypertensive patients participating in the Styrian Hypertension Study (mean age, 61±11 years; 53% women). Median plasma PTH (interquartile range) determined after an overnight fast was 49 pg/mL (39-61), mean daytime BP was 131/80±12/9 mm Hg, and mean nocturnal BP was 115/67±14/9 mm Hg. In multivariate regression analyses adjusted for BP and PTH-modifying parameters, PTH was significantly related to nocturnal systolic and diastolic BP (adjusted β-coefficient 0.140 [P=.03] and 0.175 [P<.01], respectively). PTH was not correlated with daytime BP readings. These data suggest a direct interrelationship between PTH and nocturnal BP regulation. Whether lowering high PTH concentrations reduces the burden of high nocturnal BP remains to be shown in future studies. ©2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26456544      PMCID: PMC8031576          DOI: 10.1111/jch.12710

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  37 in total

1.  Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men.

Authors:  Rolf Jorde; Johan Svartberg; Johan Sundsfjord
Journal:  J Hypertens       Date:  2005-09       Impact factor: 4.844

Review 2.  Parathyroid hormone and cardiovascular disease events: A systematic review and meta-analysis of prospective studies.

Authors:  Adriana J van Ballegooijen; Ilse Reinders; Marjolein Visser; Ingeborg A Brouwer
Journal:  Am Heart J       Date:  2013-03-26       Impact factor: 4.749

3.  Relationship between serum parathyroid hormone levels in the elderly and 24 h ambulatory blood pressures.

Authors:  L Morfis; P Smerdely; L G Howes
Journal:  J Hypertens       Date:  1997-11       Impact factor: 4.844

Review 4.  Hyperparathyroidism.

Authors:  William D Fraser
Journal:  Lancet       Date:  2009-07-11       Impact factor: 79.321

Review 5.  Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.

Authors:  Andreas Tomaschitz; Eberhard Ritz; Burkert Pieske; Jutta Rus-Machan; Katharina Kienreich; Nicolas Verheyen; Martin Gaksch; Martin Grübler; Astrid Fahrleitner-Pammer; Peter Mrak; Hermann Toplak; Elisabeth Kraigher-Krainer; Winfried März; Stefan Pilz
Journal:  Metabolism       Date:  2013-10-02       Impact factor: 8.694

6.  Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.

Authors:  Jenifer M Brown; Jonathan S Williams; James M Luther; Rajesh Garg; Amanda E Garza; Luminita H Pojoga; Daniel T Ruan; Gordon H Williams; Gail K Adler; Anand Vaidya
Journal:  Hypertension       Date:  2013-11-04       Impact factor: 10.190

7.  Chronic continuous PTH infusion results in hypertension in normal subjects.

Authors:  H N Hulter; J C Melby; J C Peterson; C R Cooke
Journal:  J Clin Hypertens       Date:  1986-12       Impact factor: 3.738

8.  Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis.

Authors:  Cortney Bosworth; Michael C Sachs; Daniel Duprez; Andrew N Hoofnagle; Joachim H Ix; David R Jacobs; Carmen A Peralta; David S Siscovick; Bryan Kestenbaum; Ian H de Boer
Journal:  Clin Endocrinol (Oxf)       Date:  2013-05-20       Impact factor: 3.478

9.  Parathyroid hormone and the risk of incident hypertension.

Authors:  Eric N Taylor; Gary C Curhan; John P Forman
Journal:  J Hypertens       Date:  2008-07       Impact factor: 4.844

10.  Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Richard Eastell; Maria Luisa Brandi; Aline G Costa; Pierre D'Amour; Dolores M Shoback; Rajesh V Thakker
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

View more
  5 in total

Review 1.  Primary hyperparathyroidism and hypertension.

Authors:  Sarah B Fisher; Nancy D Perrier
Journal:  Gland Surg       Date:  2020-02

2.  Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial.

Authors:  Julia Wetzel; Stefan Pilz; Martin R Grübler; Astrid Fahrleitner-Pammer; Hans P Dimai; Dirk von Lewinski; Ewald Kolesnik; Sabine Perl; Christian Trummer; Verena Schwetz; Andreas Meinitzer; Evgeny Belyavskiy; Jakob Völkl; Cristiana Catena; Vincent Brandenburg; Winfried März; Burkert Pieske; Helmut Brussee; Andreas Tomaschitz; Nicolas D Verheyen
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-08-20       Impact factor: 3.738

3.  Diagnostic performance of bone metabolic indexes for the detection of stroke.

Authors:  Li Ming Tan; Lu Wang; Juan-Juan Chen; Hua Li; Wen-Bo Luo
Journal:  Saudi Med J       Date:  2017-01       Impact factor: 1.484

4.  Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study.

Authors:  Nicolas D Verheyen; Katharina Kienreich; Martin Gaksch; Adriana J van Ballegooijen; Martin R Grübler; Briain Ó Hartaigh; Johannes Schmid; Astrid Fahrleitner-Pammer; Elisabeth Kraigher-Krainer; Caterina Colantonio; Evgeny Belyavskiy; Gerlies Treiber; Cristiana Catena; Helmut Brussee; Burkert Pieske; Winfried März; Andreas Tomaschitz; Stefan Pilz
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-10-12       Impact factor: 3.738

5.  Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial.

Authors:  Martin R Grübler; Martin Gaksch; Katharina Kienreich; Nicolas Verheyen; Johannes Schmid; Bríain W J Ó Hartaigh; Georg Richtig; Hubert Scharnagl; Andreas Meinitzer; Burkert Pieske; Astrid Fahrleitner-Pammer; Winfried März; Andreas Tomaschitz; Stefan Pilz
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-04-21       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.